BRPI0907086A2 - Composição para uso na redução da aparência de linhas finas ou rugas ou para a redução da inflamação da pele com ingredientes ativos aromáticos e uso de 4-etil-3,7-dimetilocta -1,6-dien-3-ol ou 2-isobutil-4-metiltetra-hidro-2h-piran-4-ol para a preparação de uma composição para o tratamento ou prevenção de uma condição da pele - Google Patents

Composição para uso na redução da aparência de linhas finas ou rugas ou para a redução da inflamação da pele com ingredientes ativos aromáticos e uso de 4-etil-3,7-dimetilocta -1,6-dien-3-ol ou 2-isobutil-4-metiltetra-hidro-2h-piran-4-ol para a preparação de uma composição para o tratamento ou prevenção de uma condição da pele Download PDF

Info

Publication number
BRPI0907086A2
BRPI0907086A2 BRPI0907086-9A BRPI0907086A BRPI0907086A2 BR PI0907086 A2 BRPI0907086 A2 BR PI0907086A2 BR PI0907086 A BRPI0907086 A BR PI0907086A BR PI0907086 A2 BRPI0907086 A2 BR PI0907086A2
Authority
BR
Brazil
Prior art keywords
composition
reducing
metiltetra
isobutil
hidro
Prior art date
Application number
BRPI0907086-9A
Other languages
English (en)
Inventor
Walke Bob
Gomez Cristie
Florence Tiffany
Hines Michelle
Original Assignee
Mary Kay Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mary Kay Inc. filed Critical Mary Kay Inc.
Publication of BRPI0907086A2 publication Critical patent/BRPI0907086A2/pt
Publication of BRPI0907086B1 publication Critical patent/BRPI0907086B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0907086-9A 2008-02-01 2009-01-29 Composição para uso na redução da aparência de linhas finas ou rugas BRPI0907086B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2563108P 2008-02-01 2008-02-01
US61/025,631 2008-02-01
US12/105,957 2008-04-18
US12/105,957 US20090197939A1 (en) 2008-02-01 2008-04-18 Methods of treating skin with aromatic skin-active ingredients
PCT/US2009/032430 WO2009099890A2 (en) 2008-02-01 2009-01-29 Methods of treating skin with aromatic skin-active ingredients

Publications (2)

Publication Number Publication Date
BRPI0907086A2 true BRPI0907086A2 (pt) 2020-06-16
BRPI0907086B1 BRPI0907086B1 (pt) 2021-06-22

Family

ID=40932318

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0907086-9A BRPI0907086B1 (pt) 2008-02-01 2009-01-29 Composição para uso na redução da aparência de linhas finas ou rugas

Country Status (11)

Country Link
US (3) US20090197939A1 (pt)
EP (1) EP2257284B1 (pt)
KR (1) KR101199672B1 (pt)
CN (2) CN103919767B (pt)
BR (1) BRPI0907086B1 (pt)
CA (1) CA2713770C (pt)
EA (1) EA020293B1 (pt)
ES (1) ES2540743T3 (pt)
HK (1) HK1199834A1 (pt)
MX (2) MX360399B (pt)
WO (1) WO2009099890A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9284274B2 (en) 2005-12-07 2016-03-15 Ramot At Tel-Aviv University Ltd. Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US9284252B2 (en) 2009-06-09 2016-03-15 Sepal Pharma Ltd. Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
US9585823B2 (en) 2010-01-07 2017-03-07 The Gillette Company Personal care compositions comprising a multi-active system for down regulating cytokines irritation
US9044429B2 (en) 2010-01-15 2015-06-02 The Gillette Company Personal care compositions comprising a methyl naphthalenyl ketone or a derivative thereof
EP2755643B1 (en) * 2011-09-16 2019-05-08 Nanocare Technologies, Inc. Compositions of jasmonate compounds and methods of use
US9402794B2 (en) * 2011-12-07 2016-08-02 Mary Kay Inc. Topical skin care formulation
EP2902022B1 (en) 2012-09-28 2020-10-28 Shiseido Company Ltd. Vegfc production promoter
EP3240524B1 (en) 2014-12-30 2020-01-01 Unilever N.V. A skin lightening composition comprising 4-hexylresorcinol and ilomastat
MX2017008655A (es) 2014-12-31 2018-04-10 Nanocare Tech Inc Derivados de jasmonato y composiciones de los mismos.
EP3280410A4 (en) 2015-04-06 2018-12-19 The Trustees Of The University Of Pennsylvania Compositions and methods for decreasing, or preventing or reversing gain of, skin pigmentation in a mammalian subject
US20170000713A1 (en) * 2015-06-30 2017-01-05 The Gillette Company Personal care compositions comprising a sensate
US9789070B2 (en) * 2015-07-28 2017-10-17 Elc Management Llc Sheet packs for treating facial or body surfaces
ITUA20163604A1 (it) 2016-05-19 2017-11-19 Giuliani Spa Composti atti a promuovere la crescita dei capelli nell'uomo e/o a fermarne o ritardarne la caduta, e composizioni per tali usi
KR101702389B1 (ko) * 2016-06-22 2017-02-03 연세대학교 산학협력단 이오논 또는 이의 염을 유효성분으로 함유하는 피부보습 개선, 피부각질 제거, 피부탄력 증진, 홍반 억제, 피부주름 개선 또는 피부광노화 개선 효과를 갖는 조성물
CN106822067A (zh) * 2017-01-22 2017-06-13 新乡医学院 治疗动脉粥样硬化的药物组合物及该药物组合物的应用
KR101777992B1 (ko) * 2017-04-03 2017-09-12 연세대학교 산학협력단 자스몬(Jasmone) 또는 이의 염을 유효성분으로 함유하는 피부주름 개선, 보습, 탄력증진, 각질제거, 홍반억제 또는 피부광노화 개선용 조성물
KR20220048378A (ko) * 2020-10-12 2022-04-19 주식회사 에피바이오텍 디하이드로퓨란-2(3h)-온 이량체를 포함하는 피부미백용 조성물

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6461622B2 (en) * 1994-09-07 2002-10-08 Johnson & Johnson Consumer Companies, Inc. Topical compositions
US6147037A (en) * 1996-08-19 2000-11-14 The Procter & Gamble Company Fragrance delivery systems
US6126930A (en) * 1997-02-13 2000-10-03 The Procter & Gamble Company Spray compositions
DE60001997T2 (de) * 1999-02-19 2004-02-26 Givaudan S.A. 6-Substituierte 3-Methyloct-6-enole
JP2001207188A (ja) * 2000-01-28 2001-07-31 Pola Chem Ind Inc 過酸化脂質消去用の香料組成物
US6495497B1 (en) * 2001-09-26 2002-12-17 International Flavors & Fragrances Inc. Use of 4-ethyloctanal in perfume compositions
US20040137024A1 (en) * 2002-10-29 2004-07-15 L'oreal Smoothing out wrinkles with a fragrancing composition
KR100962988B1 (ko) * 2003-02-07 2010-06-10 (주)아모레퍼시픽 Ｍｕｓｋ를 함유하는 피부건조 개선용 피부외용제 조성물
FR2856295B1 (fr) * 2003-06-18 2008-03-28 Jean Noel Thorel Methode de traitement esthetique, pour lutter contre l'apparition des rides et/ou les attenuer
US20060084589A1 (en) * 2004-10-20 2006-04-20 Vlad Florin J Solubilizing systems for flavors and fragrances
GB0425305D0 (en) 2004-11-17 2004-12-15 Givaudan Sa Bactericidal formulations
US20060263308A1 (en) * 2005-05-17 2006-11-23 Ivonne Brown Method for improving skin radiance and luminosity
EP1928244A4 (en) * 2005-08-18 2009-07-15 Univ Rutgers INFLAMMATORY ACTIVITY OF PHENETHYLISOTHIOCYANATE (PEITC) AND PREPARATION OF BARBAREA VERNA SEEDS CONTAINING THEREOF
DE102006035789A1 (de) * 2006-07-28 2008-01-31 Beiersdorf Ag Kosmetische Zubereitung umfassend Folsäure und Parfumbestandteile
KR101234024B1 (ko) * 2006-10-31 2013-02-19 (주)아모레퍼시픽 백매화의 향취를 재현한 향료 조성물
JP5452228B2 (ja) * 2006-10-31 2014-03-26 株式會社アモーレパシフィック 梅の香臭を再現した香料組成物
DE102007026049A1 (de) * 2007-05-31 2008-12-04 Beiersdorf Ag Repellentien gegen Wespen
EP2014273A1 (de) * 2007-06-14 2009-01-14 Symrise GmbH & Co. KG Verwendung von Menthylmethylether und weiterer Ether zum Erzeugen eines Sauberkeits- und/oder Reinlichkeitsgefühls
DE102007038413A1 (de) * 2007-08-09 2009-02-12 Beiersdorf Ag Kosmetische Emulgatorkombination

Also Published As

Publication number Publication date
EP2257284A2 (en) 2010-12-08
HK1199834A1 (zh) 2015-07-24
CA2713770C (en) 2016-09-20
CN101496799B (zh) 2014-04-16
EA020293B1 (ru) 2014-10-30
KR20090084624A (ko) 2009-08-05
US20190314295A1 (en) 2019-10-17
CN103919767A (zh) 2014-07-16
WO2009099890A3 (en) 2009-11-05
US20100249222A1 (en) 2010-09-30
EP2257284B1 (en) 2015-03-25
BRPI0907086B1 (pt) 2021-06-22
MX2010008293A (es) 2011-03-15
ES2540743T3 (es) 2015-07-13
US8399521B2 (en) 2013-03-19
CA2713770A1 (en) 2009-08-13
CN101496799A (zh) 2009-08-05
KR101199672B1 (ko) 2012-11-09
CN103919767B (zh) 2016-03-09
EA201001195A1 (ru) 2011-04-29
MX360399B (es) 2018-10-31
WO2009099890A2 (en) 2009-08-13
US20090197939A1 (en) 2009-08-06

Similar Documents

Publication Publication Date Title
BRPI0907086A2 (pt) Composição para uso na redução da aparência de linhas finas ou rugas ou para a redução da inflamação da pele com ingredientes ativos aromáticos e uso de 4-etil-3,7-dimetilocta -1,6-dien-3-ol ou 2-isobutil-4-metiltetra-hidro-2h-piran-4-ol para a preparação de uma composição para o tratamento ou prevenção de uma condição da pele
BRPI0923589A2 (pt) uso de uma composição espumável essencialmente livre de ingredientes farmaceuticamente ativos para o tratamento da pele humana.
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
IL219239A (en) Peptides for use in the treatment of skin, mucous membranes and / or hair and their use in cosmetic and pharmaceutical preparations
IL214462A0 (en) Peptides used in the treatment and/or care of the skin, mucous membranes and/or scalp and their use in cosmetic or pharmaceutical compositions
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
BRPI0816214B8 (pt) uso cosmético, composição cosmética e/ou dermatológica, e, métodos para o tratamento cosmético da pele, para o tratamento cosmético de sinais cutâneos de envelhecimento e/ou fotoenvelhecimento e para o tratamento cosmético para prevenir e/ou tratar substâncias queratinosas secas
IL206080A (en) A pharmaceutical preparation for the treatment and / or prevention of bone and joint disease
BR112012008854A2 (pt) combinação, kit de combinação, uso de uma combinação, composição farmacêutica, e, método para tratar câncer em um ser humano
IL211907A (en) A herbal formulation containing a combination of plants, an anticancer preparation containing the formulation and the use of a formulation to prepare a drug for the treatment and / or prevention of cancer
WO2009101503A3 (fr) Utilisation de substances actives naturelles dans des compositions cosmétiques ou thérapeutiques
EP3085365A3 (en) Synergistic combinations of carotenoids and polyphenols
WO2010070675A8 (en) Topical formulation(s) for the treatment of inflammation, skin and mucosal disorders and other diseases thereof
BRPI0717462A2 (pt) Emprego de valerato de estradiol ou 17 beta- estradiol em combinação com dienogest na terapia oral para manutenção e/ou aumento da libido feminin
BR112012029746A2 (pt) composição para tratamento da pele, método para fornecer um efeito microbicida para pele e uso de uma combinação
IL212567A (en) Zaxanthin, alone or in combination with rutin, spermidine, or both, for the treatment of scalp disorders, use of zaxanthin, alone or in combination with rutin, spermidine or both, for the preparation of a medicinal or cosmetic or nutritional preparation for the treatment of scalp, and a medicinal, cosmetic or nutritional preparation containing Alone or in a mixture with routine, spermidine, or both
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
BRPI1011624A2 (pt) composição, métodos para reduzir um ou mais efeitos colaterais da terapia de glicocorticóide, e para tratar ou previnir um padrão de secreção de glicocorticóide endógeno diminuído ou interrompido em um paciente.
IL215840A (en) Arylsulfonamide compounds are converted into two positions 2 and 5, their pharmaceutical composition containing them and their use in the treatment of ccr3-related diseases
BRPI1009741A2 (pt) composição, método para prevenir ou tratar a mucosite em paciente mamífero, composição farmacêutica para adminstração tópica, e uso de uma composição
BRPI0913839A2 (pt) composição farmacêutica com glicosaminoglicanos e uso da mesma no tratamento de úlceras crônicas
WO2010131038A3 (en) Steroid containing composition and uses thereof
BRPI0905994A2 (pt) "composição higienizadora, método de fabricação da composição, composição de tratamento pronta para ser utilizada, método de preparação da composição de tratamento pronta para ser utilizada, método de combate a microorganismos em um lócus, alimento, remédio ou produto de lavanderia higienizados e uso da composição"
IL204957A (en) Derivatives of 3 - (aminoalkoxyimino) - androstane and androsten
GB2441599B (en) Novel base material for pharmaceutical and/or cosmetic cream with herbal composition for itchy or infected skin caused by bacteria or fungi

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/01/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, , QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 15A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2759 DE 21-11-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.